PMID- 35096362 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20231105 IS - 2040-6223 (Print) IS - 2040-6231 (Electronic) IS - 2040-6223 (Linking) VI - 13 DP - 2022 TI - Computerized migraine diagnostic tools: a systematic review. PG - 20406223211065235 LID - 10.1177/20406223211065235 [doi] LID - 20406223211065235 AB - BACKGROUND: Computerized migraine diagnostic tools have been developed and validated since 1960. We conducted a systematic review to summarize and critically appraise the quality of all published studies involving computerized migraine diagnostic tools. METHODS: We performed a systematic literature search using PubMed, Web of Science, Scopus, snowballing, and citation searching. Cutoff date for search was 1 June 2021. Published articles in English that evaluated a computerized/automated migraine diagnostic tool were included. The following summarized each study: publication year, digital tool name, development basis, sample size, sensitivity, specificity, reference diagnosis, strength, and limitations. The Quality Assessment of Diagnostic Accuracy Studies (QUADAS) tool was applied to evaluate the quality of included studies in terms of risk of bias and concern of applicability. RESULTS: A total of 41 studies (median sample size: 288 participants, median age = 43 years; 77% women) were included. Most (60%) tools were developed based on International Classification of Headache Disorders criteria, half were self-administered, and 82% were evaluated using face-to-face interviews as reference diagnosis. Some of the automated algorithms and machine learning programs involved case-based reasoning, deep learning, classifier ensemble, ant-colony, artificial immune, random forest, white and black box combinations, and hybrid fuzzy expert systems. The median diagnostic accuracy was concordance = 89% [interquartile range (IQR) = 76-93%; range = 45-100%], sensitivity = 87% (IQR = 80-95%; range = 14-100%), and specificity = 90% (IQR = 77-96%; range = 65-100%). Lack of random patient sampling was observed in 95% of studies. Case-control designs were avoided in all studies. Most (76%) reference tests exhibited low risk of bias and low concern of applicability. Patient flow and timing showed low risk of bias in 83%. CONCLUSION: Different computerized and automated migraine diagnostic tools are available with varying accuracies. Random patient sampling, head-to-head comparison among tools, and generalizability to other headache diagnoses may improve their utility. CI - (c) The Author(s), 2022. FAU - Woldeamanuel, Yohannes W AU - Woldeamanuel YW AUID- ORCID: 0000-0003-4879-6098 AD - Division of Headache & Facial Pain, Department of Neurology & Neurological Sciences, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305, USA. FAU - Cowan, Robert P AU - Cowan RP AD - Division of Headache & Facial Pain, Department of Neurology & Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA. LA - eng GR - K01 NS124911/NS/NINDS NIH HHS/United States GR - R01 CA239714/CA/NCI NIH HHS/United States PT - Journal Article DEP - 20220124 PL - United States TA - Ther Adv Chronic Dis JT - Therapeutic advances in chronic disease JID - 101532140 PMC - PMC8793115 OTO - NOTNLM OT - automated migraine diagnosis OT - computerized migraine diagnosis OT - digital health OT - migraine OT - systematic review COIS- Conflict of interest statement: The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. EDAT- 2022/02/01 06:00 MHDA- 2022/02/01 06:01 PMCR- 2022/01/24 CRDT- 2022/01/31 05:58 PHST- 2021/09/14 00:00 [received] PHST- 2021/11/18 00:00 [accepted] PHST- 2022/01/31 05:58 [entrez] PHST- 2022/02/01 06:00 [pubmed] PHST- 2022/02/01 06:01 [medline] PHST- 2022/01/24 00:00 [pmc-release] AID - 10.1177_20406223211065235 [pii] AID - 10.1177/20406223211065235 [doi] PST - epublish SO - Ther Adv Chronic Dis. 2022 Jan 24;13:20406223211065235. doi: 10.1177/20406223211065235. eCollection 2022.